Patent Results
Human Anti-rankl Antibodies
- Published: Feb 10, 2011
- Filed: Aug 3, 2010
- Earliest Priority: Aug 07 2009
- Family: 2
- Cited Works: 68
- Cited by: 15
- Cites: 47
- Sequences: 207
- Additional Info: Cited Works Full text Published Sequence
- Applicant: Schering Corp, Xoma Technology Ltd, Hollenbaugh Diane, Levy Raphael
Transgenic Non-human Assay Vertebrates, Assays & Kits
- Published: May 2, 2013
- Filed: Oct 26, 2012
- Earliest Priority: Oct 28 2011
- Family: 6
- Cited Works: 21
- Cited by: 17
- Cites: 25
- Sequences: 2
- Additional Info: Cited Works Full text Published Sequence
- Applicant: Kymab Ltd, Bradley Allan, Lee E-chiang, Liang Qi
トランスジェニック非ヒトアッセイ脊椎動物、アッセイおよびキット
- Published: Jan 22, 2015
- Filed: Oct 26, 2012
- Earliest Priority: Oct 28 2011
- Family: 6
- Cited Works: 2
- Cited by: 0
- Cites: 2
- Sequences: 2
- Additional Info: Cited Works Sequence
- Applicant: カイマブ・リミテッド
Fully Human Antibodies Against Human Rankl
- Published: Mar 5, 2015
- Filed: Aug 24, 2013
- Earliest Priority: Aug 24 2013
- Family: 1
- Cited Works: 4
- Cited by: 1
- Cites: 2
- Additional Info: Cited Works Full text Published
- Applicant: Pharm Overseas Inc R
Non-human Animals Having A Humanized A Proliferation-inducing Ligand Gene
- Published: May 28, 2015
- Filed: Nov 10, 2014
- Earliest Priority: Nov 19 2013
- Family: 26
- Cited Works: 30
- Cited by: 1
- Cites: 6
- Sequences: 26
- Additional Info: Cited Works Full text Published Sequence
- Applicant: Regeneron Pharma
Mouse Rankl Mutant Expression Vector, And Construction, Expression And Application Thereof
- Published: Feb 24, 2016
- Filed: Apr 14, 2014
- Earliest Priority: Apr 14 2014
- Family: 1
- Cited Works: 3
- Cited by: 0
- Cites: 0
- Additional Info: Cited Works
- Applicant: Jiangsu Inst Nuclear Medicine
Non-human Animals Having A Humanized A Proliferation-inducing Ligand Gene
- Published: Aug 15, 2017
- Filed: Dec 5, 2014
- Earliest Priority: Nov 19 2013
- Family: 26
- Cited Works: 34
- Cited by: 0
- Cites: 6
- Sequences: 26
- Additional Info: Cited Works Full text Sequence
- Owner: Regeneron Pharmaceuticals Inc
- Applicant: Regeneron Pharma
Antibodies, Variable Domains And Chains Tailored For Human Use
- Published: Oct 10, 2017
- Filed: May 2, 2013
- Earliest Priority: May 02 2013
- Family: 3
- Cited Works: 628
- Cited by: 1
- Cites: 195
- Sequences: 481
- Additional Info: Cited Works Full text Published Sequence
- Owner: Kymab Limited
- Applicant: Kymab Ltd
Manipulation Of Immunoglobulin Gene Diversity And Multi-antibody Therapeutics
- Published: Oct 10, 2017
- Filed: Mar 19, 2014
- Earliest Priority: May 01 2013
- Family: 2
- Cited Works: 571
- Cited by: 1
- Cites: 174
- Sequences: 50
- Additional Info: Cited Works Full text Published Sequence
- Owner: Kymab Limited
- Applicant: Kymab Ltd
Animal Models And Therapeutic Molecules
- Published: Feb 20, 2018
- Filed: Apr 11, 2016
- Earliest Priority: Mar 28 2012
- Family: 7
- Cited Works: 637
- Cited by: 0
- Cites: 193
- Sequences: 132
- Additional Info: Cited Works Full text Published Sequence
- Owner: Kymab Limited
- Applicant: Kymab Ltd
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}}
{{::'analysis.preview.view.full' | message}}
Add New Note
Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?